Table 1.
Baseline characteristics
| Characteristic | Value |
|---|---|
| Age group | |
| ≤60 y | 212 (22.3) |
| >60 but ≤70 y | 442 (46.4) |
| >70 but ≤80 y | 275 (29.0) |
| ≥80 y | 19 (2.0) |
| Median interval since treatment (y) | 5.53 |
| Treatment | |
| RP | 510 (53.8) |
| Nerve-sparing RP | 228 |
| Non–nerve-sparing RP | 282 |
| ADT+RT | 225 (23.7) |
| RT alone | 213 (22.5) |
| Clinical T stage | |
| T1 | 403 (42.5) |
| T2 | 393 (41.4) |
| T3 | 75 (7.9) |
| T4 | 4 (0.42) |
| Unknown | 73 (7.7) |
| Comorbidity | |
| Cardiovascular | 171 (18.0) |
| Noncardiovascular | 530 (55.9) |
| None | 247 (26.0) |
ADT, androgen-deprivation therapy; RP, radical prostatectomy; RT, radiotherapy.
Data presented as numbers, with percentages in parentheses, unless otherwise noted.